Company Directory > CDMO > Phlow Corporation

Phlow Corporation

Richmond, Virginia, USA
VISIT WEBSITE
Phlow Corp. is a U.S.-based public benefit corporation that develops and domestically manufactures active pharmaceutical ingredients (APIs), key starting materials (KSMs), and finished pharmaceutical products critical to the nation's healthcare. Founded in 2019-2020 by Dr. Eric S. Edwards and Frank Gupton, Phlow operates as a contract development and manufacturing organization (CDMO) focused on solving America's pharmaceutical supply chain vulnerabilities. The company leverages advanced manufacturing processes, including continuous manufacturing technologies and AI-driven systems, to produce essential medicines on U.S. soil, with particular emphasis on pediatric products and medicines in shortage.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:-
Industry:Pharmaceuticals / Biotechnology
Sub-Industry:Contract Manufacturing / CDMO
SIZE & FINANCIALS
Employees:51-200
Revenue:Privately held, revenue not disclosed
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Series C
Total Raised:$93M+ private capital + $600M+ government contracts
Investors:Align Private Capital LLC (Series C lead, 2025), Multiple new and follow-on investors (Series C, 2025)
PIPELINE
Stage:Commercial manufacturing
Lead Drug Stage:Commercial/FDA approved generics
Modalities:Small molecule, APIs (Active Pharmaceutical Ingredients), Key Starting Materials (KSMs), Finished pharmaceutical products
Active Trials:0
Trial Phases:-
CORPORATE STRUCTURE
Key Partnerships:Antheia (advanced manufacturing technologies for key starting materials, 2024-2025), U.S. Pharmacopeia (USP) (continuous manufacturing and analytical excellence), Enveda (AI-driven API manufacturing process development), OrbitalRX (pharmaceutical supply chain management for hospitals), Fresenius Kabi (epinephrine API manufacturing), JPEO CBRN (Joint Program Executive Office for Chemical, Biological, Radiological, Nuclear Defense), Children's Hospital Coalition (founding member)
COMPETITION
Position:Emerging
Competitors:Laurus Labs, Neuland, NGL Fine Chem, Lonza, Thermo Fisher Scientific, Ardena, Avid Bioservices, Other CDMO market players
LEADERSHIP
Key Executives:
Eric S. Edwards, MD, PhD - CEO & Co-Founder
Frank Gupton - Co-Founder
Dan Hackman - President
Dawn Von Rohr - Chief Operating Officer
Scientific Founders:Frank Gupton (VCU College of Engineering)
LINKS
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Phlow Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Phlow Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.